Atlas Trials

Zostavax® at Minimum Release Specification Approaching Expiry (V211-044)

Clinical trial NCT00681031 · COMPLETED

Trial details

NCT number
NCT00681031
Sponsor
Merck Sharp & Dohme LLC
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Herpes Zoster
Start date
2008-05-14
Primary completion
2008-06-25
Enrollment
96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.